Pharma Journalist

PURIFY – Chromatography Purification Conclave
2022-12-14 | Taj Skyline, Ahmedabad
PURIFY Conclaves are pioneers of dedicated conferences in India that will help stretch possibilities, be it discovery, development or scaleups!
The pharmaceutical industry continues to dwell deeper into the growing possibilities for chromatography purification; the PURIFY conclaves touches upon diverse aspects of chromatography purification.
The attendees at PURIFY get exposed to a myriad of topics that could change the way they work…change the way they purify. New separation techniques and approaches, niche topics, deeper understanding of preparative and process chromatography and allied fields, and upcoming application areas that will provide quality substance to the discerning scientists. So, if you wish to get that additional gram, which is purer, in as less a time, with minimal resources…there will surely be something for you at PURIFY conclaves!
The annually occurring PURIFY Conclave is an initiative by Custage Marketing Solutions LLP, a Mumbai based company.
The PURIFY conclave is attended by analytical and research chemists, scientists with scale-up and process development knowledge, managers, group heads, natural product purification experts, experts from quality and manufacturing, academicians, policy makers, supply chain heads etc. of this pharmaceutical – APIs, peptides, proteins, oligonucleotides, chiral molecules, bio-pharmaceutical, fine chemicals, environmental studies, food and beverage, polymers, biotechnology, cosmetics and fragrance to understand the advancements in chromatography platforms.
So, the purification expert in you will surely get answers to the daily challenges faced for you in your laboratories. And what’s more, the knowledge comes to you from dignitaries who are institutions on their own in chromatography purification and related.

Pre-Filled Syringes and Injectable Drug Devices Europe
2023-01-10 - 2023-01-12 | London, UK
SAE Media Group’s 15th Annual Conference
Pre-Filled Syringes and Injectable Drug Devices Europe
January 10 – 12 2023 | London, UK
http://www.pre-filled-syringes.com/pharmajournalist
————————————————————————-
The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to increase patient centricity, aid self-administration and deliver biologics that have large-volumes and novel formulations. This year’s conference will explore the exciting advances in the combination product drug delivery space and a future outlook exploring how pharma, device developers and regulators can work together to encourage innovation.

SAE Media Group’s 15th Annual Pre-Filled Syringes and Injectable Drug Devices Conference will be bigger than ever, with a pre-conference focus day exploring the advances in PFS design for enhanced drug delivery proceeded by a two-day main conference comprising of morning keynote plenaries and parallel afternoon topic streams as detailed below:

Novel Drug Products and Large Volume Delivery
Sustainability for Injectable Delivery Devices
Primary Packaging Development
Connected Drug Delivery Devices

Topics of discussion will include the latest updates in the combination product regulatory framework, insights into the evolving digital health landscape for connected delivery devices, considerations for the development of primary packaging, utilising platform technology, the delivery of novel drug formulations and large volume drug products, patient centric approaches to device design as well as sustainable approaches for device development.
This event will not only bring you key insights you need to expand and enhance your injectable device portfolio but will also give you the opportunity to network with key players throughout the industry.
Benefits of Attending:

Engage with industry representatives on the latest trends within the pre-filled syringe and injectable device market
Hear about new technological advances in the delivery of large volume drugs
Explore updates to drug device combination product design approaches considering patient preference at the forefront with case studies from big pharma representatives
Understand the latest regulatory requirements from regulatory experts surrounding medical devices and digital health
Delve into the considerations for material components for the development of primary packaging
Gain insight into how big pharma are incorporating sustainable approaches into drug device design

Who should attend:
Advanz Pharma; AstraZeneca; Balda Medical GmbH & Co. KG; Bayer AG; Bayer Pharma; BD Medical; BD Medical – Pharmaceutical Systems; Becton Dickinson (BD); Boehringer Ingelheim; Boehringer Ingelheim GmbH & Co. KG; Boehringer Ingelheim Pharma GmbH & CO KG; Boehringer Ingelheim Pharma Gmbh & Co. Kg; BSI; BSI Group; Chiesi Ltd; Crux Product Design Ltd; DCA Design International; Device Development; Dr.Reddys; GlaxoSmithKline; GSK; Hoffmann-La Roche; Horizon Therapeutics GmbH; Ichnos Sciences; Janssen Pharmaceutical Companies; Johnson & Johnson; Johnson & Johnson (Janssen Pharmaceutical); Medincell; Merck Group; Midas Pharma Gmbh; Nemera; Novartis; Novo Nordisk; Novo Nordisk A/S; Owen Mumford; Pfizer; Pfizer UK; PharmaEssentia; Prescient Healthcare Group; RAUMEDIC AG; Sanofi; SCHOTT AG; SPM MEDICARE PVT LTD, INDIA; Sustainable Healthcare Coalition; Takeda; Teva; Teva Pharmaceuticals; Teva Pharmaceuticals Industries Ltd.; Teva, Combination Products; TUV Italia SRL; TUV SUD Japan Ltd.; TUV SUD Product Service GmbH; University of Liverpool; University of Southern Denmark; Zeon Europe GmbH; Zeon Specialty Materials ;
SAE Media Group offer direct access to key decision makers through tailored sponsorship and exhibitor packages.
For details, please contact Daniele Moreschi on: +44 (0)20 7827 6050 or dmoreschi@smi-online.co.uk
For all delegate enquiries, contact Jamie Wilkinson on: +44 (0) 20 7827 6136 or jwilkinson@smi-online.co.uk
About SAE Media Group Conferences:
SAE Media Group Conferences connects global communities with focused networking conferences. We provide our customers with solutions through industry knowledge and collaboration that enables our attendees to return to their organisations better equipped to overcome their key business challenges. Our key events focus on Defence and Aerospace, Pharmaceutical and Medical. Each year we bring together over 5,000 senior business professionals at our conferences. http://www.smgconferences.com
SAE Media Group (SMG), a subsidiary of SAE International, reports the latest technology breakthroughs and design innovations to a global audience of nearly 1,000,000 engineers, researchers, and business managers. SMG provides critical information these professionals need to develop new and improved products and services.

11th Annual Pharmaceutical Microbiology Conference
2023-01-16 - 2023-01-17 | London, United Kingdom
11th Annual Pharmaceutical Microbiology Conference
16 – 17 January 2023
London, UK
http://www.pharma-microbiology.com/PJwl
Sponsored by: Microgenetics
Co-chairs Di Morris, Clinical Auditor, AstraZeneca and Nigel Cryer, Deputy Director Global Audit, Sanofi
Harnessing Alternative Rapid Microbial Methods for a Successful Contamination Control Strategy

We are delighted to announce SAE’s 11th Annual Pharmaceutical Microbiology Europe Conference taking place in London, UK on the 16-17 January 2023.
Microbiology remains an essential tool for the detection of microorganisms present in biopharmaceutical and pharmaceutical batches. This conference will explore the most pressing topics in this thriving field, from the movement toward process automation and increased regulatory stringency, to the latest technologies in rapid microbiological testing methods and data integrity.
Event Hashtag: #MicrobiologyEurope
Key Highlights for 2023 Conference:

Optimise your contamination control strategy and review the initial impact of Annex 1
Learn how to utilise the latest microbiological methods to modernise your contamination control strategy
Maximise the data output from your environmental and microbial monitoring with proven strategies and technologies
Increase the diversity of your testing methodologies through industry case studies including the recombinant factor C assay and Monocyte Activation Test

Who Should Attend?
Heads of Microbiology, Heads of Aseptic Processing, Global Quality Directors, Heads of GMP Compliance, Quality & Compliance Heads, Microbiology Senior Specialists, Directors of Quality Control Biology, Quality Control Managers, Quality Assurance Managers, Lean Managers, Operations Managers, Heads of Site Compliance, Heads of Sterile Technology, Global Microbiology Analytical Experts, Cleanroom Managers, Regulatory Affairs Managers, Production Managers, Quality Systems Managers
Download the brochure at: http://www.pharma-microbiology.com/PJwl

Spatial Biology for Immuno-Oncology Summit
2023-01-17 - 2023-01-19 | The Westgate Hotel, 1055 2nd Ave, San Diego, CA, 92101, United States
The inaugural Spatial Biology for Immuno-Oncology Summit runs at a crucial moment in time. Spurred on by technological advancement and successful case studies, spatial technologies are set to become increasingly mainstream and accessible. If you’re not already, now is the time to harness spatial technologies to power your immunotherapy research, improve your clinical trials, enhance your biomarker discovery, and streamline your therapeutic development.
Uniting researchers, technology providers, and drug developers, next January join your peers to hear the latest best-practice case studies on operationalizing technology, integrating spatial into the clinic, and developing a robust data analysis pipeline. This meeting will provide an unrivaled opportunity to solve your current spatial challenges to improve your ability to treat disease and identify drug targets in immuno-oncology.
Across 3 jam-packed days of content, led by 20+ immuno-oncology leaders, the Spatial Biology for Immuno-Oncology Summit is your only chance to discover how technologies that put omics and single-cell information in spatial context can improve your ability to treat disease and identify drug targets in immuno-oncology.
Join over 100 key industry stakeholders as they gather and leave no stone unturned to advance the application of this revolutionary technology.
To know more visit: https://bit.ly/3yYeUhw

Transdermal and Microneedle Drug Delivery
2023-01-23 - 2023-01-24 | London, UK
SAE Media Group’s 2nd Annual Conference
Transdermal and Microneedle Drug Delivery
January 23 – 24, 2023 | London, UK
www.transdermal-microneedle-delivery.co.uk/pharmajournalistel
————————————————————————-
SAE Media Group is proud to present the 2nd annual Transdermal and Microneedle Drug Delivery Conference, taking place on the 23rd to 24th January 2023.

The 2023 Transdermal and Microneedle Drug Delivery Conference will explore real world applications of microneedles in drug delivery and strategies for advanced and user-centric device design. Regulation of transdermal delivery systems will be another key theme addressed, in combination with clinical trial optimization. Engage in the latest innovations in device design, development and formulation, with case studies from expert key opinion leaders of this rapidly accelerating space. Other key areas will be microneedle vaccines and transdermal patches for management of chronic disease.
The two-day agenda offers you peer-to-peer networking with CEO’s, Senior Vice presidents, Directors, Heads of Product Development and many more.
BENEFITS OF ATTENDING:

Engage with senior industry opinion leaders presenting their experiences and case studies in innovative device design and advanced drug product formulation
Gain insights from notified body and competent authority representatives addressing key regulatory requirements
Understand how to optimize your lifecycle management strategy for a commercially successful device
Explore and benchmark against industry advances in device design through case studies and real-world examples

WHO SHOULD ATTEND:

Drug-Delivery Device Developers
Microneedle Device Developers
Transdermal Delivery Developers
Microarray Patch Developers
Medical Device Engineers
Primary Packaging Material Designers
Secondary Packagers
Smart Device Developers
Training Device Developers
Device-Safety Solution Providers
Drug Developers
Transdermal Drug Product Developers

EARLY-BIRD RATES:

BOOK BY 30TH SEPTEMBER AND SAVE £400

Registrations can be made on the event website at: www.transdermal-microneedle-delivery.co.uk/
Targeted Keywords
Transdermal and Microneedle Drug Delivery, transdermal, drug development, regulatory guidelines, pharmaceutical industry, drug delivery, therapeutic sectors, vaccines, Parenteral administration, combination products, primary packaging, sterile injectables, connectivity, human factors, autoinjectors

2nd Annual mRNA-Based Therapeutics Summit Europe
2023-01-24 - 2023-01-26 | TBC – Berlin, Germany
The 2nd Annual mRNA-Based Therapeutics Summit Europe is the only end-to-end mRNA-dedicated meeting in Europe and the largest gathering for mRNA professionals outside of the United States.
Built with biopharmaceutical industry insights, this meeting will unite KOLs from Europe and the rest of the world to delve into the challenges associated with successfully designing and developing the next-generation of mRNA-based vaccines & therapeutics with improved specificity, delivery & efficacy for immuno-oncology, infectious diseases and beyond.
Hear from 35+ pioneering large pharma, biotech, and academic experts who are shaping the landscape of mRNA-based therapeutics and discover how they are addressing the major challenges facing the industry.
With more companies investing in their tools and technologies to innovate processes and technologies to address key challenges such as sequence optimization, cell-specific payload expression, and durability, there has never been a more pivotal time to join European biopharma experts and discuss the following topics.
-Emerging cell-enhancing or protein replacement therapies based on mRNA
-Optimization of analytical and quality control protocols
-Durability, accessibility and immunogenicity challenges of mRNA therapeutics and vaccines
-Enhancement of formulation, process development and manufacturing processes
-Need for clear regulatory path to support the technology whilst enabling speed to market
To learn more, download your copy of the full event guide including all speakers and their session details: https://ter.li/tholw0

DDR Inhibitors Summit 2023
2023-01-24 - 2023-01-26 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
The 6th DDR Inhibitors Summit is taking place in-person for the first time in 3 years in Boston, MA this January 24 – 26, 2023.
The DNA damage response inhibitor space only continues to grow, with progress being accelerated by a shift in focus onto next-generation targets like PolQ and WRN, moving forward from monotherapies through combining targets and exploiting sensitivity caused by DDRis to enhance other therapies like radiotherapy.
The scope of this year’s meeting is to bring together leading minds in DDRi drug development to exploring these strategies and aim to address issues related to emerging DDR inhibitor resistance and maximizing efficacy, as well as addressing the biggest challenge in the space right now, toxicity.
The 3-day meeting will consist of a comprehensive overview of the DDR space, with over 30+ world class speakers sharing insights preclinical updates, progress in the clinic, solutions to overcoming toxicity and improving patient selection.
Don’t miss out on hearing from the best in the field on how to overcome toxicity and resistance during drug design as well as in the clinic, to maximize efficacy and propel your DDR inhibitors to success.
To know more visit: https://ter.li/40qr50

2nd HFpEF & HCM Drug Discovery & Development Summit
2023-01-24 - 2023-01-26 | Wyndham Boston Beacon Hill, 5 Blossom St, Boston, MA, 02114, United States
The 2nd HFpEF & HCM Drug Discovery & Development Summit is the definitive industry forum dedicated to propelling drug discovery and development across emerging therapeutics including cell and gene therapies and the implementation of precision medicine.

Shake hands with industry pioneers prioritizing the development of therapeutic treatments to complement the new standard of care with SGLT2 inhibitors and understand how you can leverage advances in biomarkers for early detection of drug efficacy and clinical trial updates to inform your strategic decisions.
Join 80+ biopharma experts in research, cardiovascular, rare disease and precision medicine as they analyze the HFpEF patient population and translational drug development pathway to achieve new commercially viable and clinically accepted therapeutics.
To know more visit: https://bit.ly/3EjK5H3

3rd TGF-β for Immuno-Oncology Drug Development Summit
2023-01-30 - 2023-02-01 | Marines Memorial Club and Hotel, 609 Sutter St, San Francisco, CA, 94102, United States
Exploit Understanding of TGF-β Biology, Harness Clinically Validated Biomarkers & Advance Safe & Efficacious Clinical Programs for Maximal Therapeutics Benefit in Immuno-Oncology.
In the past year alone, the field has learnt valuable lessons from the clinical trials and from the wider TGF-β field that will equip the immuno-oncology field with the knowledge needed to supercharge future TGF-β monotherapy or combinational therapeutics for precision medicine.
From uncovering the effects and production of TGF-β in immune, tumor and stromal cells to exploring predictive and pharmacodynamic TGF-β biomarkers for patient identification and assessing the clinical challenges that led to recent clinical failures, the 3rd TGF-β for Immuno-Oncology Drug Development Summit is your one-stop-shop dedicated to harnessing you with the knowledge to unlock the potential of successfully targeting TGF-β.
Tailored with 18+ senior leaders, the 2023 meeting will be taking place in-person for the first time – don’t miss your chance to be in the room for your comprehensive guide on TGF-β in immuno-oncology!
Whether you are new to this field or a seasoned expert, this meeting will provide you with the must-know takeaways from the basic biology to biomarkers to clinical trial design to overcome the clinical setbacks and produce a blockbuster TGF-β therapeutic.
To know more visit: https://ter.li/cjnpgy

Cancer Neoantigen Vaccines
2023-02-02 | Digital Conference
Over the last few decades, immunotherapy has developed at a rapid rate in the treatment of cancer where neoantigens are the latest breakthrough in tumour immunotherapy. Today, it is still unclear when a cancer vaccine will be made commercially available; what is the latest academic research showing us? What is the industry missing and where are we going?
Join us through a series of inspiring keynote presentations and engaging panel discussions to connect with top pioneers in the space, to discuss the future of cancer immunotherapy and how neoantigens are transforming the field.
Unlock the new era of vaccine development at Cancer Neoantigen Vaccines, a 1-day digital conference taking place February 2, 2023 and discover the path to commercial success with novel approaches toward cancer neoantigen vaccines.
You’ll shape the future of next generation cancer vaccine development with new oncolytic approaches and critical immunotherapy strategies and uncover, key research on targets and evolution, how to successfully enter global markets and the future of personalisation and beyond.
You can expect to uncover methods of identifying true targets and deep dive into the future of machine and deep learning in identifying neoantigens. Plus, you’ll hear successful case studies and promising data on the latest neoantigen vaccine development and gain a deeper understanding of the future of vaccines in personalised medicine. Don’t miss your opportunity to be a part of the discussions with industry experts on their look to the future.
All of this plus much more without leaving your desk! Your digital pass gives you access to the full attendee list with video chat, instant message, and meeting request functionalities to connect with like-minded thought-leaders in the field to expand your network, and access to the content on-demand for 10 working days post-event.

14th Annual RNA Therapeutics Conference
2023-02-08 - 2023-02-09 | Copthorne Tara Hotel, Scarsdale Place, Kensington, London, W8 5SY, United Kingdom
SAE Media Group invites you to join the 14th Annual RNA Therapeutics Conference, taking place on 8 and 9 February 2023, in London, UK.
Building on the success of previous years, the RNA Therapeutics Conference will bring together industry experts from leading pharma and biotech companies to provide an expert and holistic view on the latest developments of the industry.
RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy, personalised medicines, and treatment of genetic, infectious and chronic diseases. This is reflected with the value of the global antisense & RNA therapeutics market expected to reach USD 1.81 billion by 2025, growing at a CAGR of 7.5%.
With Covid-19 rapidly accelerating the RNA landscape through massive regulatory successes, the recent advent of CRISPR, an RNA-guided gene-editing technology, as well as new strides in the delivery of messenger RNA transcribed in vitro, there has been considerable progress in the development of RNA medicines and a major expansion of the RNA-therapeutics field.
This year’s conference will reflect on how the industry has adapted and played a pivotal role in global health over the past year and will discuss the takeaways for future mRNA therapeutic development.
Benefits of attending:

Explore how mRNA leads the way in the genetic medicine space as the next generation of novel drug modalities
Investigate the latest trends in AI drug discovery as a tool for designing novel RNA based therapeutics
Enhance your knowledge of the latest innovations in RNA application and RNA delivery techniques with case studies from BioNTech, Neuway Pharma and Ethris GmbH
Engage in the growing advances and development of novel RNA molecules in the treatment of chronic respiratory, neurodegenerative, and infectious diseases

Who should attend:

Directors of novel RNA therapies
CEOs
Senior and expert scientists
Chief Medical Officers
Chief Technical Officers
Senior Vice Presidents
Global Heads of mRNA R&D
Global Medical Directors
Heads of Translational Medicine
Director, Clinical Pharmacology
Global Head of RNA and Targeted Therapeutics
Clinical Science Director
Head of Biology
Director, Genetic Medicine
Associate Director

EARLY-BIRD RATES:

REGISTER BY 31ST OCTOBER AND SAVE £400
REGISTER BY 3OTH NOVEMBER AND SAVE £200
REGISTER BY 16TH DECEMBER AND SAVE £100

Healthcare Payment & Revenue Integrity Summit
2023-02-08 - 2023-02-09 | ORLANDO, FLORIDA
Introducing the only industry forum exclusively bringing together key decision-makers, within health insurers and providers, who are responsible for payment and revenue integrity, value-based payment, and networking relations.
At a time when both payers and providers are evaluating and streamlining internal payment and revenue integrity processes, this networking conference has been established to breakdown silos, by promoting discussion between clinical, coding, revenue cycle and payment departments to facilitate the development of efficient, value-based healthcare systems.
To know more visit: https://healthcarepaymentrevenueintegritysummit.com

6th Annual 3D Cell Culture Conference
2023-02-08 - 2023-02-09 | London, UK
6th Annual 3D Cell Culture Conference
8-9 February 2022
London, UK
http://www.3D-cellculture.com/PJwl
Sponsored: CelVivo, Promega and Systemic Bio
Conference Co-chairs:
Phillip Hewitt, Global Head of Early Investigative Toxicology, Merck
Rhiannon David, Director, Microphysiological Systems, AstraZeneca
Exploring the implementation of complex in-vitro models for drug development
Join us in February 2023, as SAE Media Group’s 6th annual 3D Cell Culture Conference brings together industry experts from big pharma, regulatory bodies, and cutting-edge researchers to discuss the challenges and drivers of these medical technologies, through case studies of the latest innovations in 3D Cell Culture models, real world examples of clinical applications, and insights into regulatory validation and high throughput screening to give a comprehensive look into this fast growing industry.
3D Cell Culture has gained increasing momentum in the pharmaceutical industry over recent years, with the global 3D Cell Culture market predicted to reach a value of $3.48 Billion by 2028. The pharmaceutical industry globally is realising the growing potential of in vitro tissue models for drug discovery, pathology modelling and validation, safety and toxicity. 3D Cell Culture technology promises to offer increased translatability in models and reduce the costly rates of drug attrition in the discovery process — heralding the next major advance in the discovery of pharmaceuticals.
Event Hashtag: #3DCellCulture2023
Key Conference Highlights:

Discuss the uses of advanced cell technologies for human tissue bioengineering
Uncover the major benefits of 3D modelling in enhancing clinical translation and predictability
Utilise 3D cell culture for personalised drug screening and high-throughput screening over traditional 2D methods
Learn how to implement 3D Cell Culture techniques for antibody and cell and gene therapy discovery process
Delve into advanced case studies looking into organ models: from the blood-brain barrier to liver spheroids

Who Should Attend?
Biotech / Pharma Companies – Investigative toxicologist, Research Scientist, Clinical Pharmacologist, Cell Technologists, Cell and Molecular Scientist, Head of Translational Research, In-Vitro Toxicologists, Director of Drug Discovery, Head of DMPK, Chief Scientific Officer, R&D Scientist, Head of R&D.
Academia – Cell Technology, Stem Cell Sciences, Biochemistry, Protein Technology and Tissue Engineering
Solution Providers – Manager, Head of, CEO, Director, Founder, Account Manager, President, CSO, Executive, Managing Director, Vice President, COO, Biomedical Engineers, Head of External Collaboration
Organisations / Regulatory – Director, Senior Science Advisor, Scientific Officer, Advisor for Toxicology

CRISPR AgBio Congress 2023
2023-02-14 - 2023-02-16 | The Westin San Diego Bayview, 400 W Broadway, San Diego, CA, 92101, United States
The 5th Annual CRISPR AgBio Congress will unite research heads, molecular biologists, regulatory experts, and product developers from large Ag companies, innovative AgBiotechs, academic groups and regulatory bodies to translate share the challenges and opportunities of translating cutting-edge CRISPR technology into a tangible product. If you are working to advance genome-edited crops or plants, this is the must-attend meeting to network with the leading stakeholders progressing the space forward, keep up with the latest technology advances & guidances, and ensure your product is set up to help meet the significant food security challenges the world is currently facing.
To know more visit: https://ter.li/3nrx25

Retinal Vascular Disease Drug Development Summit
2023-02-21 - 2023-02-23 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
Retinal Vascular Disease Drug Development Summit is an event dedicated to creating a community space dedicated to overcoming the current challenges in drug development for retinal vascular diseases.
The management of these diseases has made remarkable advancements in previous years, but the burden on patients remains high, posing a need to develop novel therapeutics and delivery mechanisms that improve the efficacy and durability of anti-VEGF drugs and beyond.
Providing you with an in-depth coverage of technical insights of anti-VEGF, innovative non-VEGF targeting therapeutics for wet-AMD, DME, DR and RVO, the Retinal Vascular Disease Drug Development Summit will address the specific challenges in utilizing preclinical models for retinal vascular disease, understand key regulatory requirements, and learn how to run effective clinical trials that utilize appropriate endpoints.
Join your colleagues from across R&D, preclinical, translational and clinical teams across the biopharmaceutical industry to streamline your drug development and address the significant and increasing unmet medical need.
To know more visit: https://ter.li/7xp7xc

6th CAR-TCR Summit Europe
2023-02-21 - 2023-02-22 | ExCeL London, Royal Victoria Dock, 1 Western Gateway, London, E16 1XL, United Kingdom
Join us in London this February to connect with those trailblazing the next wave of CAR and TCR based approaches from pre-clinical development with in vivo engineering and regulatory fast-track strategies to streamlined analytics and automation to make CAR and TCR therapies better, and faster.

Take advantage of cutting-edge innovation from global biopharma leaders in cell armouring, combination approaches and multiplexing gene engineering to improve cell durability and trafficking across allogeneic and solid tumour indications, and leave understanding the technical strategies to build automated, closed-system manufacturing processes to ensure vein to vein time is less than a week.
Promising data-driven case studies outlining next generation product design, clinical trial set-up and manufacturing processes, this meeting is your go-to to comprehensively assess the emerging improvements of CAR and TCR based therapies.
See the full agenda here: https://ter.li/ulbn8o

3rd Annual Gene Therapy for Muscular Disorders Summit
2023-02-21 - 2023-02-23 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
The past twelve months have seen an unprecedented level of excitement, investment, and progression within the gene therapy for muscular disorders field. As the industry endeavours to move gene therapy treatment through the preclinical and clinical pipeline, in context of reducing toxicity and increasing efficacy, attending the 3rd Annual Gene Therapy for Muscular Disorders Summit has never been so crucial.
This year’s summit will return to Boston to reunite 100+ leading experts in biotech, pharma and academia to continue to develop strategies to deliver safer and more effective gene therapies to muscle cells.
This summit will encompass all aspects of preclinical development and highlight the obstacles in clinical trials, enabling you to address and overcome these challenges.
To know more visit: https://ter.li/wi2a51

11th Alzheimer’s & Parkinson’s DD Summit
2023-02-21 - 2023-02-23 | Hyatt Centric Fisherman’s Wharf, San Francisco, United States
Welcome to the 11th Alzheimer’s & Parkinson’s Drug Development Summit

With a surge in preclinical investment, fresh news of clinical pipeline progressions, and a new era of therapies pending FDA approvals from Biogen, Eisai, and Denali Therapeutics, 2022 has put neurodegenerative drug development back on the map.
Building on the field’s momentum, we are delighted to bring back the 11th Alzheimer’s & Parkinson’s Drug Development Summit, dedicated to overcoming the translational challenges of targeting neurodegenerative mechanisms. This summit will unite neurodegenerative biopharma experts from discovery, preclinical, translational, and clinical backgrounds to showcase the latest breakthroughs in Alzheimer’s, Parkinson’s, and related neurological disorders in 2022 and 2023
To know more visit: https://ter.li/x0w74p

2nd Next Generation Kinase Inhibitors Summit
2023-02-22 - 2023-02-23 | Boston Park Plaza, 50 Park Plaza, Boston, MA, 02116, United States
Since Kinase inhibitors have proven to be efficacious and approvable targets, fuelling recent investment into this exciting space as their therapeutic targeting is explored beyond oncology. However, increasing resistance to existing programs and safety bottlenecks threaten further progress. The next wave of kinase targets depends on innovation.
Join the 2nd Next Generation Kinase Inhibitors Summit to connect with experts across discovery, R&D, and clinical medicine to discuss how to accelerate the next generation of kinase inhibitor drugs to market, which displays maximal therapeutic efficacy and durable clinical responses.
Key Topics:

Assay Development, Kinome Exploration & and Kinase-Focussed Drug Discovery Principles
Overcoming Tumor Resistance, Managing the Tumor Microenvironment, and Improving Durability
Exploiting the RAS/MAPK Signalling Pathway
Multikinase and Combination Therapies to Overcoming Resistance
Targeting Established Pharmacological Mechanisms in Alternative Indications Beyond Oncology to Meet Unmet Needs

Don’t miss this opportunity to join & network with 100+ Kinase Biology Experts under one roof, hear from 18+ expert speakers from the space and showcase your work at the Scientific Poster Session.
This meeting is FREE for drug developers and researchers!
To know more visit: https://ter.li/sreltb

Targeted Intracellular Delivery Summit
2023-03-08 - 2023-03-09 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
Achieve Therapeutic Localization with Selective, Effective & Validated Delivery to Intracellular Targets
Optimize Your Pipeline’s Therapeutic Index with Novel Delivery Systems to Overcome Endosomal Barriers in Target Cells
Selective cell entry, biological barriers and complexities in targeting chemistry have long restricted the ability of promising drug candidates to impactfully engage their intracellular sites of action without off-target toxicity implications.
Fast forward to 2023, advances in nanomedicine technology, the LNP enabled mRNA vaccine and emphasis on personalized medicine has triggered significant pipeline shifts towards complex nucleic-acid and biologic candidates. This clinical translation depends on novel delivery systems accessing previously elusive intracellular compartments. This is further evidenced by AstraZeneca, Boehringer Ingelheim and Eli Lilly’s announcements of prioritized strategic investment in targeted intracellular delivery technologies.
At such a pivotal moment for the industry, the Targeted Intracellular Delivery Summit arrives to bring Formulation, Chemistry, Delivery & Biology industry professionals to the forefront of cutting-edge science critical to accelerate pharmaceutical R&D. Join 80+ senior leaders to explore target identification, tissue delivery, engineering technologies, endosomal escape, delivery validation analytics and more.
This is your definitive meeting for unpresented data, unrivalled insights and unmissable methodologies across the next-generation nano-platforms including LNPs, EVs, Liposomes & more, creating new opportunities for the development of safer and efficacious oligonucleotide, siRNA, mRNA, DNA delivery and protein payloads.
Unleash the true potential of your pipeline by gaining the best picture of industry’s fast-paced nano-platform progress this March!
To know more visit: https://ter.li/i23a5q

SAE Media Group Proudly Presents the 4th Annual AI in Drug Discovery Conference
2023-03-13 - 2023-03-14 | Copthorne Tara Hotel, Scarsdale Place, Kensington, London, W8 5SY, United Kingdom
SAE Media Group is proud to present its 4th Annual AI in Drug Discovery Conference, taking place from 13 – 14 March 2023 in London, UK.
With the recent pandemic highlighting the need for rapid drug discovery, AI has become an area of increased interest. This is driven by the ability to discover drugs through the use of machine and deep learning. The current challenges within the drug discovery industry include the significant time consumption and expenses involved. This conference will discuss the solutions to these problems with presentations and updates from leading industry experts.
AI in drug discovery is leading the way into a shorter, cheaper and more successful R&D era where compound generation is automated, drug synthesis is predictable and undruggable diseases are finally being targeted.
The uptake of structure-based target selection and innovative in-silico techniques are driving optimised, more efficient drug discovery. This, alongside sessions on automation, robotics and how to improve patient-centricity in precision medicine are just some of the topics set to be discussed which you wouldn’t want to miss at the 4th annual AI in Drug Discovery Conference 2023.
Our influential line-up of speakers will be taking to the stage from 13 – 14 March 2023 at the Copthorne Tara Hotel, London to provide you with the latest insights and advice for you to take back to your business.
Key Reasons to Attend:

DELVE into key industry research focuses, with talks on fragment-based selection, in silico drug design and personalised medicine from GSK, Bayer, Janssen Pharmaceuticals and more
INCREASE the diversity of your drug discovery programme with case studies in applying knowledge graphs, molecular dynamic simulations, and digital twins throughout the development process
UTILISE breakthroughs in robotics, automation and quantum chemical methods alongside AI to drive the next generation of drug discovery
UNCOVER the role that international cooperation and open-source data played in the rapid development of Covid-19 treatments, and how this can be an example for the future of pharmaceutical R&D
LEARN how to implement AI and Machine Learning techniques throughout the discovery pipeline from antigens and genomics to proteins and peptides

To know more visit: www.ai-indrugdiscovery.com/PJ-EL

6th Annual Gene Therapy for Rare Disorders 2023 Summit
2023-03-20 - 2023-03-23 | Sheraton Boston Hotel, 39 Dalton Street, Boston, MA, 02199, United States
As the gene therapy field continues to break records, there are still significant challenges to overcome relating to safety, efficacy, and accessibility. The 6th Annual Gene Therapy for Rare Disorders 2023 Summit remains devoted to showcasing the top case studies and strategic learnings from the past year. With an expert speaking faculty devoted to bringing safer and more effective gene therapies to rare disease patients, key questions will be answered on how best the field can overcome regulatory, clinical, manufacturing and pricing bottlenecks to progress gene therapies into and through the clinic.
500+ leading experts from innovative biotechs, large pharma, academia and key service providers will be reuniting in Boston for 2023 to capitalize on recent success stories and collaborate over the most pressing industry challenges. An event vital to unlocking the full potential of your rare gene therapy program, join us to keep your finger on the pulse and set up for success in 2023.
To know more visit: https://ter.li/bvmkei

Reuters Events: Pharma USA 2023
2023-03-28 - 2023-03-29 | Pennsylvania Convention Center, 1101 Arch St, Philadelphia, PA, 19107, United States
Patient-first. Collaborative. Data and insights driven. Digitally underpinned.
These are the qualities of a healthcare system that actively serves its purpose – yet instead, the US is hindered by mounting financial toxicity, unprecedented politicization of science and eroding public trust.
To capitalize on three years of extraordinary momentum and lead healthcare’s reform, pharma must embody the traits that healthcare needs to thrive and restructure in pursuit of change.
Seize the moment at Reuters Events: Pharma USA 2023 to lead pharma’s internal revolution and drive this critical systemic transformation. Join North America’s visionary pharma changemakers, leading solution providers, patient experts and industry heavyweights to catapult commercial excellence, ingrain patient-first strategies into the heart of pharma’s fabric and heed the long-awaited rebirth of America’s healthcare system.
To know more visit: https://bit.ly/3uJUp5O

8th Innate Killer Summit
2023-03-28 - 2023-03-30 | HILTON LA JOLLA TORREY PINES, 10950 N. Torrey Pines Road, La Jolla, CA, 92037, United States
Dedicated to driving cost-effective, efficacious, safe, durable, scalable, and globally accessible allogeneic, cell-based, and engager therapies, the 8th Innate Killer Summit returns to cement your end-to-end education in innate immune therapeutics. Your industry-defining Innate Killer Summit brings crucial insights for everyone on your team, with 4 content tracks spanning preclinical development, clinical translation, CMC, process development, and clinical scale manufacturing, this is the definitive meeting to drive concept to commercial success of emerging innate immune therapies.
Download your copy of the Full Event Guide here.
Join over 250 experts from 120+ pioneering companies to drive novel gene engineering technologies, gain regulatory know-how, optimize lymphodepletion and cryopreservation, and contrast cell sources for highly efficacious, scalable off-the-shelf therapies.
Promising brand-new speakers from new companies, interactive discussion, and engaging networking opportunities, attend to forge new collaborations and realize the clinical potential of innate immune therapies.
Register your place here.

4th TCR-based Therapies for Solid Tumors Summit
2023-04-03 - 2023-04-05 | Hyatt Regency Boston, One Ave. de Lafayette, Boston, MA, 02111, United States
The first TCR-based therapy approval in the US and Europe at the start of last year sparked a rush of excitement, investment and collaborations. As further developers move into the clinic and some near commercialization, it’s time for this community to unite to address the critical bottlenecks faced in development, from discovery to approval, to guarantee smooth sailing through the clinic.
The 4th TCR-based Therapies for Solid Tumors Summit is returning to Boston as the must-attend forum for TCR experts to come together to share industry updates and next generation engineered approaches to boost therapy safety and efficacy.
Join leaders and newcomers including Immunocore, Medigene, Immatics, Captain T Cell and Anocca as they collaborate to guarantee tumor-specificity, prevent cross-reactivity, boost TCR and target discovery, enhance solid tumor durability and explore TCR modalities.
Huge milestones were achieved for the TCR field in 2022, however, there’s no time to sit back and relax. Collaborate with like-minded TCR trailblazers to secure clinical validation and streamline the road from discovery to commercialization.
To know more visit: https://ter.li/h6mn96

3rd Annual Ligase Targeting Drug Development Summit
2023-04-11 - 2023-04-13 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
Hijacking E3 Ligases to Mediate Degradation & Modulation of Undrugged Targets
As a family of over 600 known proteins, ligases pose immense potential as viable avenues for harnessing previously undrugged targets. Key challenges remain however to rapidly discover and identify novel and underexploited ubiquitin E3s. Furthermore, bottlenecks exist in the development of the established ligases; Cereblon and VHL.

It is now critical that we harness Cryo-EM, X-Ray crystallography, and other visualization tools to fully understand the structure and function of these lesser-known E3s, accelerate ligand screening with new and improved tools, leverage advances in DMPK knowledge to address concerns over toxicity in Cereblon, propel VHL from ‘academic’ to clinic, and all in, de-risk the translation of candidate ligases to the clinic.
The 3rd Ligase Targeting Drug Development Summit is returning with fresh understanding and data from the forerunners of the field and those who have recently joined the space. Together we will investigate ligase structural and functional biology, screening tools for optimal ligase, linker, and ligand identification, explore tissue specificity, uncover the key modalities where ligases can succeed, and showcase the novel assays that are maximizing validation to ensure success in the clinic.
This dedicated forum will provide an unrivaled meeting point for industry leaders all under one specialized forum to strategically accelerate and de-risk the process of identifying, validating, and therapeutically leveraging cell and tissue-specific ubiquitin E3 ligases for degradation or modulation of targets in oncology, immunology, and beyond.
To know more: https://ter.li/gapgsb

2nd LNP Formulation & Process Development Summit
2023-04-17 - 2023-04-19 | The Westin Boston Seaport District, 425 Summer Street, Boston, MA, 02210, United States
Turbocharging Your Next Gen LNP End-To-End Development to Deliver Curative Promises to Patients
Following exciting industry updates from Verve Therapeutics’ GalNAc-LNP for PCSK9 for HFpEF treatment, to Recode’s 5th element, the 2nd LNP Formulation & Process Development Summit is your must-attend meeting as this nanoparticle continues to dominate the biopharmaceutical industry in 2023.
New for 2023, we have curated 3 streams of content for 2nd iteration of the summit:

In depth discussions divulging IP and regulatory compliance for LNP drug products
Maximized LNP flexibility and versatility for payloads beyond mRNA vaccines with other RNA, DNA, gene therapy and gene editing possibilities
Lipid Chemistry & Discovery Track: Novel lipid discovery and particle engineering to customize LNP composition for next generation delivery vehicle
Formulation & Process Development Track: Optimize your LNP development techniques for enhanced manufacturability and product quality, and overcome stability issues of LNP-nucleic acid drug products
LNP CMC & Manufacturing Track: Elevating your process control, CQAs framework for CMC, GMP compliance for seamless scale-up

This summit will offer the most comprehensive content and exclusive data, equipping you with end-to-end LNP development journey to exploit this lucrative non-viral delivery vehicle for various payloads to your destined cells and organs.
In collaboration with Intellia Therapeutics, Pfizer, Sanofi, ReCode Therapeutics, Akagera Medicines, the 2nd LNP Formulation & Process Development Summit is committed to serving you with their lessons learned to supercharge your pipeline and deliver curative promises to patients.
Join us to stay at the forefront of science, network with 350+ LNP Biology, Chemistry, Formulation & Process Development, Tech Ops & Manufacturing experts to gain competitive advantage to exploit LNP potentials!
To know more visit: https://ter.li/ol6e27

3rd Fc Receptor Pathway Targeted Therapies 2023
2023-04-18 - 2023-04-20 | The Colonnade Hotel, 120 Huntington Ave, Boston, MA, 02116, United States
The field of FcRn receptor targeting is gaining ground-breaking speed as Argenx, Janssen, UCB and Immunovant compete to tackle myasthenia gravis and biopharma invest in transformative immunological therapy for autoimmune diseases as the next big drug opportunity.
The 3rd Fc Receptor Pathway Targeted Therapies Summit will once again feature unmissable conversations to advance targeting FcR and the subsequent generation of Fc manipulation since real-world proof and clinical value are now at the industry’s fingertips.
Join 100+ of your colleagues at the 3rd Fc Receptor Pathway Targeted Therapies Summit – from the fields of immunology, antibody engineering, pharmacology, toxicology, and immuno-oncology for three days of content that is unmatched in its scope, all focused on the optimization of FcRn, FcγR, and novel Fc.
Put your stake in the ground to revolutionise autoimmune illness and position yourself in front of the next wave of blockbuster drug development.
To know more visit: https://ter.li/y9vxt6

mRNA Process Development & Manufacturing Europe
2023-04-18 - 2023-04-20 | Sheraton Offenbach Hotel, Am Buesing Palais, Berliner Str. 111,, Offenbach am Main, 63065, Germany
mRNA therapeutics have catapulted into the limelight amidst the COVID-19 pandemic with multiple EMA approvals to help combat the virus.
Bringing together KOLs sharing case studies with actionable insights, the inaugural mRNA Process Development & Manufacturing Summit Europe has been established as the first forum in Europe to support your in-house process development and manufacturing strategies.
The 3-day agenda has been carefully co-authored along with the leaders within the industry from the likes of BioNTech, AstraZeneca and Genentech. A snapshot of key topics include:

Assessing how dsRNA formation can be limited to reduce the purification requirements of the manufacturing process with BioNTech SE
Uncovering how to maximise biocomparability when scaling up the batch manufacturing process, including identifying the critical process steps that introduce batch-to-batch variability with Genentech & Roche
A snapshot of robust, high-throughput online novel assays for identifying impurities with CureVac & AstraZeneca
Understanding critical quality attributes and the differences in process development considerations for mRNA therapeutics and vaccines to achieve appropriate drug substance quality with the University of Sheffield & University Hospital Zurich
Hearing how the global market could function with a standard process platform to benefit all patients with Medicines Patent Pool

This is an opportunity to join 80+ mRNA enthusiasts from mRNA manufacturing, analytics, process development, CMC, quality control, and drug substance to get key insights on scaling up mRNA drug substances in Europe whilst navigating mRNA process development and manufacturing regulatory guidelines to create commercially successful mRNA vaccines and therapeutics.
To know more visit: https://ter.li/f3ec38

10th Annual Pre-Filled Syringes East Coast Conference
2023-04-24 - 2023-04-25 | Boston, USA
10th Annual Pre-Filled Syringes East Coast Conference
April 24 – 25, 2023
Boston, USA
Driving Innovations in Device Design, Connectivity and Sustainability for Advanced Parenteral Combination Product
https://www.pfsamericas.com/PJ-Event-listing
The 10th annual Pre-Filled Syringes East Coast conference will once again play host to an international audience of drug delivery, medical device and PFS experts to discuss emerging trends and offer innovative solutions to the challenges facing the pre-filled syringes industry, helping attendees to secure global success for their devices.
The past year has seen significant developments in the injectables landscape with the evolving regulatory landscape, accelerating opportunities in digitilization and simulation to improve device design efficiency, and increased opportunities for connectivity to improve the user experience.
Furthermore, with a growing need for circular economy, this year’s conference will assess case studies of sustainable approaches for device packaging and life cycle management, while panel discussions, FDA and BioPhorum addresses will evaluate current and upcoming combination product guidelines and the potential for harmonization.
As part of SAE Media Group’s leading drug delivery portfolio of events, this event will bring you the key insights you need to expand and enhance your injectable device portfolio and the opportunity to network with senior players throughout the industry.
Benefits of Attending:

Discover the latest industry developments for improved large volume and high viscous delivery via advanced autoinjector and on body delivery system design
Assess the growing opportunities of digitalization and simulation for improved device development efficiency and potential
Engage in an FDA regulatory roundup from the office of combination products, insights into EPR identification from BioPhorum and a panel discussion assessing harmonization of the regulatory landscape
Delve into emerging technologies in injectable device design and case studies on digital integration of medical devices for improved user experience

Benchmark against sustainable device packaging case studies driving the combination product industry towards circular economy
